Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand.
The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
The health status covers health indicators (life expectancy, mortality, and aging population assessment) and disease burden assessment (top 10 diseases and government initiative to address the disease burden).
The healthcare system assessment comprises infrastructure assessment (number of public and private hospitals by bed strength, number of public and private medical colleges, and number of health community centers), healthcare expenditure (healthcare spending per capita, public expenditure on health as a percentage of GDP, total expenditure on health as a percentage of GDP, and per capita government expenditure on health at average exchange rate in USD), and insurance landscape (extent of public, private, and out-of-pocket insurance coverage, number of public and private insurance companies, and government sponsored health insurance schemes).
The healthcare regulatory landscape covers assessment of healthcare regulatory bodies (healthcare providers, healthcare payers, and medical devices) and medical device registration process (procedure, documents/dossier required, timeline, and fees), and regulatory reforms.
The medical device infrastructure assessment is segmented into installed base of medical devices (MRI, CT Scans, Ultrasound, and X-rays) and medical devices infrastructure improvement initiatives undertaken by government and medical device manufacturers. The hospital chain assessment in top 10 hospitals in each country assesses the overview, services offered, financial performance, key growth strategies, and recent developments for each hospitals.
Table Of Contents
1 Health Status
1.1 Health Indicators
1.1.1 Life Expectancy
1.1.2 Mortality Rate
1.1.2.1 Overall Mortality Rate
1.1.2.2 Under-Five Mortality Rate
1.1.2.3 Infant Mortality Rate
1.1.2.4 Neo-Natal Mortality Rate
1.1.3 Aging Population Assessment
1.1.3.1 Male
1.1.3.1.1 Historical
1.1.3.1.2 Current (2014)
1.1.3.1.3 Projected (2020)
1.1.3.2 Female
1.1.3.2.1 Historical
1.1.3.2.2 Current (2014)
1.1.3.2.3 Projected (2020)
1.2 Disease Burden Assessment
1.2.1 Top 10 Diseases
1.2.1.1 Epideomology
1.2.1.2 Prevalence/Incidence
1.2.1.3 Diagnostic Rate
1.2.1.4 Treatment Rate
1.2.1.5 Treament Options
1.2.1.6 Average Cost Of Therapy
1.2.2 Government Initatives (To Address Disease Burden)
2 Healthcare System Assessment
2.1 Infrastructure Assessment
2.1.1 Hospitals
2.1.1.1 Number Of Public Hospitals, by Bed Strength
2.1.1.1.1 Below 100
2.1.1.1.2 100 To 300
2.1.1.1.3 300 and Above
2.1.1.2 Number Of Private Hospitals, by Bed Strength
2.1.1.2.1 Below 100
2.1.1.2.2 100 To 300
2.1.1.2.3 300 and Above
2.1.2 Number Of Diagnostic Centers/Clinics
2.1.3 Number Of Medical Colleges
2.1.3.1 Public
2.1.3.2 Private
2.1.4 Number Of Health Community Centers
2.1.4.1 Cardiovascular Centers
2.1.4.2 Orthopedic Centers
2.1.4.3 Maternity Centers
2.1.4.4 Dental Centers
2.1.4.5 Others
2.2 Healthcare Expenditure
2.2.1 Healthcare Spending/Capita
2.2.2 Public Expenditure On Health As A Percentage Of GDP
2.2.3 Total Expenditure On Health As A Percentage Of GDP
2.2.4 Per Capita Government Expenditure On Health At Average Exchange Rate (USD)
2.3 Insurance Landscape
2.3.1 Extent Of Insurance Coverage
2.3.1.1 Public
2.3.1.2 Private
2.3.1.3 Out-Of-Pocket
2.3.2 Number Of Insurance Companies
2.3.2.1 Public
2.3.2.2 Private
2.3.3 Government Sponsored Health Insurance Schemes
3 Healthcare Regulatory Landscape
3.1 Healthcare Regulatory Bodies
3.1.1 Healthcare Providers
3.1.2 Healthcare Payers
3.1.3 Medical Devices
3.2 Medical Device Registration Process
3.2.1 Procedure
3.2.2 Documents/Dossiers Required
3.2.3 Timeline
3.2.4 Fees
3.3 Regulatory Reforms (If Applicable)
4 Medical Devices Infrastructure Assessment
4.1 Installed Base (2014)
4.1.1 Mri
4.1.2 Ct Scans
4.1.3 Ultrasound
4.1.4 X-Rays
4.2 Medical Devices Infrastructure Improvement Initiatives
4.2.1 Government
4.2.2 Medical Device Manufacturers
5 Hospital Chain Assessment In Top 10 Hospitals
5.1 Hospital 1
5.1.1 Overview
5.1.2 Service Offerings
5.1.3 Financial Performance
5.1.4 Key Growth Strategy
5.1.5 Developments
5.2 Hospital 2
5.3 Hospital 3
5.4 Hospital 4
5.5 Hospital 5
5.6 Hospital 6
5.7 Hospital 7
5.8 Hospital 8
5.9 Hospital 9
5.10 Hospital 10
6 Geographic Scope:
6.1. India
6.2. China
6.3. Japan
6.4. Singapore
6.5. Indonesia
6.6. Thailand
6.7. Malaysia
6.8. Vietnam
6.9. Australia
6.10. New Zealand
*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
Growth opportunities and latent adjacency in Asia Pacific Healthcare Market